The 4 Stocks That Dominated the Market ThursdayBy Paul Ausick March 12, 2015 4:01 pm EDTPrintEmail March 12, 2015: Markets opened higher on Thursday even though the report on U.S. retail sales was disappointing. Foreign markets contributed an interest rate cut (Korea), better-than-expected employment data (Australia), and rumors of more stimulus (China). Gold ticked up today, and crude oil dropped […]
Sellers woke up from the weekend and hit the market hard today with volume soaring along with the US Dollar. The Dow Jones Industrial average fell more than 300 points leading all indexes lower with the Russell 2000 holding up the best. Biotech stocks held up relatively well despite the selling in the broader market. Clearly many traders are worried […]
Industrials
General Motors Company (GM) Stock Trading At 10.5% Discount: Citi
Citi analysts believe General Motors Company stock should trade higher; boost price target to $50
GM
F
By: Larry DarrellPublished: Mar 10, 2015 at 1:18 pm EST
In a report published Tuesday, Citi lifted its price target on General Motors Company (NYSE:GM) stock by $1 to $50, and reiterating a Buy rating. The sell-side research […]
Capitalist Bull: Price Action Impressive Volume Not So Much
PagesHome
Leading Growth Stocks Analysis
Short Trading Ideas
SERVICES
Newsletter Sign Up
Interviews
About Us
Disclaimer
Price Action Impressive Volume Not So MuchMarket price action has been impressive by any respect. Despite persistent bad news from around the world, and numerous internal red flags, the NYSE advance decline line continues to trade near new highs, and the market marches higher […]
MRK -0.30%ABT +0.13%AMGN +0.40%Health care stocks were mostly higher, with the NYSE Health Care Sector Index climbing 0.3% and shares of health care companies in the S&P 500 advancing 0.6% as a group.In company news, Athersys (ATHX) advanced Monday after the biotech company lined up Japanese drugmaker Chugai to help it develop its stem-cell therapy for stoke.Under terms of the […]
Investors have a lot to cheer about these days. The bull market is now six years old, the major stock market averages have hit new all-time highs, and most major companies seem to be raising their dividends year after year. That is the case for most companies, but certainly not all. In fact, some major outfits have been forced to lower their […]
Stocks moved smartly to new highs in the major averages this past week. Sector rotation was particularly noteworthy, with former leaders utilities and consumer staples–defensive and yield plays–falling behind and more growth-oriented sectors–consumer discretionary and raw materials–showing particular strength. This reflects strength in U.S. economic data and an increased pricing of odds that the Fed will begin to normalize interest […]
View photo.Biotech stocks have performed well in the recent bull market.Since January 1, 2008, the SPDR S&P Biotech ETF (NYSE: XBI) has outperformed the SPDR S&P 500 ETF Trust (NYSE: SPY), gaining 233 percent compared with just 41.3 percent gains in SPY.Analysts at Sterne Agee took a closer look at three active biotech companies in separate notes Friday morning.Molina Healthcare, […]
Jeff Sprecher, chief executive of the US exchanges operator, acknowledged the fragmented, regulated world of equities trading was not “ever going to be wildly profitable”, but added the value of the NYSE lay in its listings franchise and data business.”I don’t know why we would get rid of that. I think our shareholders want to participate in the earnings growth […]
Wednesday’s sessions was volatile marked by a sharp spike down in the closing moments of the day as news broke that the European Central Bank revoked a waiver that allowed banks to use Greek government debt as collateral for loans. The decision will force Greek lenders, who since 2010 had been able to access funds from the ECB against junk-rated […]
